Quest for a drug that lowers an artery-clogging particle nears finish line
High levels of lipoprotein(a) often go undetected and can afflict seemingly healthy people. A clinical trial will show whether lowering levels can reduce risk of heart disease.
View original article
Contributor: Daniel Gilbert
